Skip to main content
Cancer Biology & Therapy logoLink to Cancer Biology & Therapy
. 2019 Dec 3;21(4):388. doi: 10.1080/15384047.2019.1699718

Correction notice

PMCID: PMC7515502  PMID: 31791176

Article Title: Identification of TDP-43 as an oncogene in melanoma and its function during melanoma pathogenesis

Authors(s): Qinghai Zeng, Ke Cao, Rui Liu, Jinhua Huang, Kun Xia, Jintian Tang, Xiang Chen, Ming Zhou, Huiqing Xie, and Jianda Zhou

Journal: Cancer Biology & Therapy

Bibliometrics: Published 2017, VOL. 18, NO. 1, pp.8–15

DOI: 10.1080/15384047.2016.1250984.

Publisher: Taylor & Francis

In “Identification of TDP-43 as an oncogene in melanoma and its function during melanoma pathogenesis. by Zeng Q, et al.” which was published in 2017, VOL. 18, NO. 1, pp.8–15, an inadvertent mistake was made under Figure 4, wherein panel D was error. The corrected figure along with the corresponding legend is provided below. The change does not affect any conclusions of the study.

Figure 4.

Figure 4.

Knockdown of GLUT4 reduces proliferation and metastasis of melanoma cells. (A) Western Blot confirmed that GLUT4 siRNA can significantly knockdown the expression of GLUT4. (B) MTT assay showed decreased proliferative ability in GLUT4 siRNA-transfected A375 and GLUT4 siRNA-transfected WM451 cells than that in NC cells. (C-D) Scratch and Transwell invasion experiments showed inhibited migration and invasion ability in A375 and WM451 cells after down regulation of GLUT4. ***P <0.001, **P < 0.01, *P < 0.05.

The authors would like to apologize for any inconvenience caused.


Articles from Cancer Biology & Therapy are provided here courtesy of Taylor & Francis

RESOURCES